Physician profile
Erin N Wait
NPI 1245597087
$1,196.85
in general payments reported to CMS, 2019-2025
21 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2023: $565 · 2024: $184 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,008 · Education: $61.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,008.23 |
| Education | $61.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $263.48 | 2023-2025 | Veozah |
| Abbvie INC. | $180.97 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Pacira Pharmaceuticals Incorporated | $124.01 | 2023 | Exparel |
| Sumitomo Pharma America, INC. | $118.80 | 2023-2025 | Myfembree |
| Shield Therapeutics INC | $66.57 | 2023-2024 | Accrufer |
| Duchesnay USA Incorporated | $45.13 | 2019 | |
| Mayne Pharma Commercial LLC | $41.15 | 2023-2025 | |
| Pfizer INC. | $40.73 | 2024-2025 | |
| Dexcom, INC. | $40.08 | 2023 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $38.58 | 2019-2025 | |
| Evofem Biosciences, INC. | $37.28 | 2024-2025 | Phexxi, Solosec, Phexx |
| Exeltis, USA INC. | $30.73 | 2023-2024 | Slynd |
| Organon LLC | $28.42 | 2025 | Nexplanon |
| Biogen, INC. | $24.01 | 2025 | Zurzuvae |
| Medtronic, INC. | $20.10 | 2025 | Ligasure |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.75 | 2019 | |
| Hologic Sales and Service, LLC | $18.31 | 2025 | Novasure |
| Minerva Surgical, INC | $16.44 | 2023 | |
| Amag Pharmaceuticals, INC. | $14.93 | 2019 | |
| Novo Nordisk INC | $14.37 | 2019 | |
| Ascend Therapeutics US, LLC | $14.01 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Wait listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.